Yahoo Finance Site Map
ArticlesFor a comprehensive guide to our content, please see the Site Index
SiteMap 2023 > 10 > 22
Other dates of the month:
- Energy & precious metals - weekly review and outlook
- Top 5 things to watch in markets in the week ahead
- UPDATE 2-Canada's St. Lawrence Seaway workers to go on strike, Unifor union says
- John Lewis under fire for affordable housing plans
- Vunani (JSE:VUN) Has Affirmed Its Dividend Of ZAR0.09
- INSIGHT-Iran's quandary: How to stay out of Israel's war on Hamas
- Reunert's (JSE:RLO) Returns On Capital Not Reflecting Well On The Business
- Will Weakness in Metall Zug AG's (VTX:METN) Stock Prove Temporary Given Strong Fundamentals?
- Investors Shouldn't Overlook Morefield Group's (AMS:MORE) Impressive Returns On Capital
- Revolution Medicines Presents Promising Clinical Activity and Safety Data from Phase 1/1b Trial of RMC-6236
- Datopotamab Deruxtecan Plus Durvalumab Demonstrated Robust and Durable Tumor Responses in First-Line Treatment of Patients with Metastatic Triple Negative Breast Cancer in BEGONIA Phase 1b/2 Trial
- Detailed Results from Phase 3 CABINET Pivotal Trial Evaluating Cabozantinib in Advanced Neuroendocrine Tumors Presented at ESMO 2023
- Final Multivariate Analysis from the Phase 3 MAGNITUDE Study Shows Trend Toward Improvement in Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer with BRCA Alterations Treated with Niraparib and Abiraterone Acetate Plus Prednisone
- Meier Tobler Group AG's (VTX:MTG) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
- SKAN Group AG's (VTX:SKAN) top holders are insiders and they are likely disappointed by the recent 5.8% drop
- Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for Palazestrant
- Rolls-Royce facing £350m class action lawsuit from investors
- Artificial Intelligence Market in the Education Sector to Grow by USD 1,100.07 million from 2022 to 2027 | The increasing emphasis on customized learning paths using AI drives market growth - Technavio
- An Intrinsic Calculation For Centaur Media Plc (LON:CAU) Suggests It's 48% Undervalued
- Agilysys (AGYS) To Report Earnings Tomorrow: Here Is What To Expect
- Jacobio Pharma Presents Clinical Results of Glecirasib in Combination with JAB-3312 at ESMO
- Fresenius Medical Care AG & Co. KGaA (ETR:FME) is a favorite amongst institutional investors who own 42%
- Is Sun International Limited's (JSE:SUI) ROE Of 58% Impressive?
- Energiekontor (ETR:EKT) Could Become A Multi-Bagger
- Vietnamese sandwich shop coming to Holland Township
- Israel tells Gazans to move south or risk being seen as 'terrorist' partner
- Institutional investors have a lot riding on MorphoSys AG (ETR:MOR) with 49% ownership
- Nagarro (FRA:NA9) Is Achieving High Returns On Its Capital
- UPDATE 2-Israel tells Gazans to move south or risk being seen as 'terrorist' partner
- Declining Stock and Solid Fundamentals: Is The Market Wrong About Plan Optik AG (ETR:P4O)?
- With 35% stake, Barloworld Limited (JSE:BAW) seems to have captured institutional investors' interest
- Even though Northam Platinum Holdings (JSE:NPH) has lost R2.2b market cap in last 7 days, shareholders are still up 228% over 5 years
- Final Multivariate Analysis from the Phase 3 MAGNITUDE Study Shows Trend Towards Improvement in Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer with BRCA Alterations Treated with Niraparib and Abiraterone Acetate Plus Prednisone
- Power Electronics Market to grow by USD 9.44 billion from 2022 to 2027 | Market is driven by the innovations to reduce the design time of power electronic systems - Technavio.
- Shareholders in Access Intelligence (LON:ACC) are in the red if they invested a year ago
- Time for central bank digital currencies to prove their worth
- Taking A Look At Sulzer Ltd's (VTX:SUN) ROE
- The past year for Ringmetall (ETR:HP3A) investors has not been profitable
- First Results with Erdafitinib-Releasing Intravesical Delivery System (TAR-210) Show Early Evidence of Positive Clinical Activity in Patients with Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations
- Raludotatug Deruxtecan Continues to Demonstrate Promising Clinical Activity in Patients with Advanced Ovarian Cancer in Early Trial
- TAR-200 Intravesical Delivery System Results Show 77 Percent Complete Response Rate in Patients with Bacillus-Calmette-Guérin Unresponsive, High-Risk Non-Muscle-Invasive Bladder Cancer
- Gamma Communications (LON:GAMA) Will Want To Turn Around Its Return Trends
- Is Begbies Traynor Group plc (LON:BEG) Trading At A 44% Discount?
- Sutro Biopharma Announces Presentation of Data for Luveltamab Tazevibulin (luvelta) from the Phase 1 Dose-Expansion Study in Endometrial Cancers at ESMO 2023
- Investors in Ibstock (LON:IBST) have unfortunately lost 32% over the last five years
- Flash News: OKX Wallet Now Integrated with ZNS Connect
- Smart Metering Systems (LON:SMS) investors are sitting on a loss of 9.4% if they invested a year ago
- Shareholders in Swatch Group (VTX:UHR) are in the red if they invested five years ago
- Oxford Biomedica's UK£39m Market Cap Fall Books Insider Losses
- One FD Technologies Insider Raised Stake By 24% In Previous Year